全球呼吸治療設備市場

到 2030 年，全球呼吸治療設備市場規模將達到 17 億美元

全球呼吸治療設備市場規模預計在2024年達到14億美元，預計在2024-2030年的分析期內將以3.6%的複合年成長率成長，到2030年將達到17億美元。診斷設備是本報告分析的細分市場之一，預計其複合年成長率為2.9%，到分析期末將達到10億美元。治療設備細分市場在分析期間內的複合年成長率預計為4.7%。

美國市場規模估計為 3.833 億美元，中國市場預計複合年成長率為 6.6%

美國呼吸治療設備市場規模預計2024年達到3.833億美元。作為世界第二大經濟體，中國市場規模預計到2030年將達到3.465億美元，在2024-2030年的分析期間內，複合年成長率為6.6%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為1.5%和2.8%。在歐洲，預計德國市場的複合年成長率為2.1%。

全球呼吸治療設備市場—主要趨勢與促進因素摘要

氣道內技術的進步如何改變肺部介入手術

什麼增強了內視鏡檢查在慢性和急性呼吸道疾病管理中的作用？

隨著肺部醫學向更微創、更精準的介入治療轉型，用於診斷和治療慢性和急性氣道疾病，呼吸治療市場正在迅速發展。慢性慢性阻塞性肺病(COPD)、支氣管狹窄、中央氣道阻塞和肺癌等疾病通常需要內視鏡治療，包括擴張、支架置入和阻塞氣道切除。這些治療擴大採用先進的內視鏡治療設備進行，例如球囊擴張器、電外科探頭、冷凍治療系統和氣道支架，從而能夠在最大程度減少對周圍組織損傷的情況下進行標靶治療。

城市污染、吸煙、人口老化和新冠併發症加劇了呼吸系統疾病的負擔，迫切需要無需大手術即可緩解呼吸系統疾病的技術。在這方面，內視鏡治療具有多種優勢，包括門診治療選擇、恢復時間短和併發症風險低。例如，在肺癌病例中，支氣管鏡治療不僅擴大用於姑息減壓，而且還用於動態療法和近距離放射治療等局部治療。這種轉變得益於影像導引導航和微型儀器的改進，它們提高了手術安全性和診斷準確性，使肺病專家能夠更精確地進入更深的肺段。

設備和診斷影像方面的哪些創新正在改變內視鏡治療設備的性能？

科技創新正在重塑呼吸治療設備的性能、設計和應用。其中一項關鍵進展是可操控一次性支氣管鏡的開發，它能夠改善在複雜氣道解剖結構中的導航能力，同時降低交叉污染的風險。這些一次性設備與即時螢光透視和電磁導航系統相結合，使臨床醫生能夠治療先前難以觸及的病變。此外，具有可調節充氣曲線的球囊擴張系統能夠實現漸進式壓力控制，從而降低擴張手術中氣道損傷的風險。

另一個重要趨勢是電外科和冷凍消融設備的小型化及其與支氣管鏡平台的整合。冷凍探針可以精確冷凍異常組織以進行切片檢查或切除，現在已有多種靈活的形式，適用於外周肺部手術。同樣，氬離子凝固術 (APC) 和射頻消融術 (RFA) 也正在被改進用於經支氣管手術，以抑制咯血和切除腫瘤。先進的支架輸送系統——通常預先安裝、自膨脹且長度和直徑可客製化——正在改善氣道狹窄和術後狹窄的治療效果。此外，內視鏡器械擴大配備感測器，可提供溫度、壓力和定位的即時回饋，從而最大限度地減少人為錯誤並提高手術的可重複性。

臨床方案和當地醫療保健基礎設施將如何影響市場滲透？

肺部治療設備的採用在很大程度上受到當地臨床通訊協定、報銷框架和介入性肺部基礎設施可用性的影響。在美國、德國、日本和韓國等高高所得地區，肺部治療正日益被三級醫療中心採用，成為診斷和治療的標準護理。這些國家的醫院擁有先進的影像設備、一體化手術室以及訓練有素的介入性肺部專科醫生，他們能夠使用各種設備。這些地區也建立了微創手術和急性期後肺部護理的報銷制度，進一步促進了肺部治療設備的採用。

相較之下，東南亞、東歐和拉丁美洲等中等收入地區對肺內治療的興趣日益濃厚，但其應用往往受到成本和專業技術匱乏的限制。然而，日益壯大的官民合作關係和基於遠端醫療的培訓平台正在幫助彌合技術差距。在印度、中國和巴西，政府和非營利舉措旨在早期發現和管理呼吸系統疾病的舉措，正在刺激對經濟高效、適應當地情況的內視鏡解決方案的需求。移動支氣管鏡檢查單元和門診介入計畫開始在都市區醫院興起，使更廣泛的患者群體能夠獲得內視鏡治療。

什麼將支持呼吸治療市場的長期成長？

呼吸治療市場的成長受到多種因素的推動，包括慢性呼吸系統疾病盛行率的上升、對微創干預的需求不斷成長以及手術工具的持續技術創新。一個關鍵的成長要素是向門診護理模式和門診病人介入的轉變。醫療保健系統面臨著降低住院費用和手術併發症的壓力，而內視鏡支氣管鏡檢查提供了一種可行的替代方案，符合基於價值的醫療目標。呼吸系統和胸部疾病早期診斷的增加進一步推動了對內視鏡支氣管鏡檢查的需求，這些疾病通常透過低劑量電腦斷層掃描和人工智慧輔助X光檢查檢測出來。

此外，介入病理學作為一個獨特的次專科，其作用日益擴大，為先進內視鏡治療工具的應用奠定了堅實的臨床基礎。醫院和訓練中心正在投資模擬實驗室、混合手術室和人工智慧引導的手術規劃系統，以支援新一代肺科專家。在技​​術方面，機器人技術、成像技術和材料科學的日益融合，正在釋放自主導航、精準藥物傳輸和具有抗炎特性的奈米塗層支架的潛力。

最後，以呼吸健康為重點的全球衛生政策舉措，例如世界衛生組織的《預防和控制非傳染性疾病全球行動計畫》，正在為該領域的投資和創新創造有利的政策環境。由於人口老化、都市區發病率上升以及呼吸道流行病的持續威脅，內視鏡治療在肺部健康管理中的作用預計將顯著提升。未來的醫療設備預計將變得更加經濟實惠、個人化和數位化，從而確保這一影響深遠的醫療領域的長期成長軌跡。

部分

設備（診斷設備、治療設備）、專業人員（醫院專業人員、診斷中心專業人員、門診手術中心專業人員）、最終使用者（周邊介入最終使用者、血管內介入最終使用者、心臟最終使用者、介入放射學最終使用者、靜脈最終使用者、其他最終使用者）

受訪公司範例

• Ambu
• Armstrong Medical
• Boston Scientific
• CONMED Corporation
• Cook Medical
• Dragerwerk
• Fisher & Paykel Healthcare
• Flexicare Medical
• Getinge
• Halyard Health（Avanos Medical）
• Hudson RCI
• Intersurgical
• Karl Storz
• Laerdal Medical
• Medtronic
• Olympus
• PENTAX Medical
• Philips（Philips Respironics）
• ResMed
• Teleflex

人工智慧整合

我們正在利用有效的專家內容和人工智慧工具來改變市場和競爭情報。

Global Industry Analysts 沒有遵循查詢 LLM 或特定產業SLM 的典型規範，而是建立了一個來自世界各地專家的精選內容庫，其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

• 市場概覽
• 主要企業
• 市場趨勢和促進因素
• 全球市場展望

第3章市場分析

• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 澳洲
• 印度
• 韓國
• 其他亞太地區
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中東
• 伊朗
• 以色列
• 沙烏地阿拉伯
• 阿拉伯聯合大公國
• 其他中東地區
• 非洲

第4章 競賽

Global Respiratory Endotherapy Devices Market to Reach US$1.7 Billion by 2030

The global market for Respiratory Endotherapy Devices estimated at US$1.4 Billion in the year 2024, is expected to reach US$1.7 Billion by 2030, growing at a CAGR of 3.6% over the analysis period 2024-2030. Diagnostic Devices, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$1.0 Billion by the end of the analysis period. Growth in the Therapeutic Devices segment is estimated at 4.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$383.3 Million While China is Forecast to Grow at 6.6% CAGR

The Respiratory Endotherapy Devices market in the U.S. is estimated at US$383.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$346.5 Million by the year 2030 trailing a CAGR of 6.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.5% and 2.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.

Global Respiratory Endotherapy Devices Market - Key Trends & Drivers Summarized

Inside the Airway: How Technological Advancements Are Transforming Interventional Pulmonary Procedures

What Is Elevating the Role of Endotherapy in Managing Chronic and Acute Respiratory Disorders?

The respiratory endotherapy devices market is rapidly gaining prominence as pulmonology transitions toward less invasive, precision-guided interventions for the diagnosis and treatment of both chronic and acute airway disorders. Conditions such as chronic obstructive pulmonary disease (COPD), bronchial stenosis, central airway obstruction, and lung cancers often require therapeutic endoscopy involving dilation, stenting, or ablation of obstructed airways. These interventions are increasingly being performed using advanced endotherapy devices, including balloon dilators, electrosurgical probes, cryotherapy systems, and airway stents, which enable targeted treatment with minimal trauma to surrounding tissues.

The rising burden of respiratory diseases-exacerbated by urban pollution, smoking, aging populations, and post-COVID complications-has created an urgent need for technologies that provide relief without resorting to major surgery. Endotherapy offers several advantages in this regard, such as outpatient feasibility, shorter recovery time, and lower risk of complications. In the context of lung cancer, for instance, bronchoscopic interventions are being used not only for palliative decompression but also for delivering localized therapy such as photodynamic treatment or brachytherapy. These shifts are supported by improvements in imaging-guided navigation and miniaturized instrumentation that enhance procedural safety and diagnostic accuracy, allowing pulmonologists to access deeper lung segments with higher precision.

What Innovations in Instrumentation and Imaging Are Transforming Endotherapy Device Performance?

Technological innovation is reshaping the performance, design, and application of respiratory endotherapy devices. One of the major advancements is the development of steerable, single-use bronchoscopes that reduce cross-contamination risks while improving navigation in complex airway anatomies. These disposable devices, paired with real-time fluoroscopy or electromagnetic navigation systems, enable clinicians to deliver therapy to previously inaccessible lesions. Moreover, balloon dilation systems with adjustable inflation profiles now provide graduated pressure control, reducing the risk of airway trauma during dilation procedures.

Another significant trend is the miniaturization and integration of electrosurgical and cryoablation devices into bronchoscopic platforms. Cryoprobes, capable of precisely freezing abnormal tissue for biopsy or ablation, are now available in flexible formats suitable for peripheral lung procedures. Similarly, argon plasma coagulation (APC) and radiofrequency ablation (RFA) tools are being adapted for transbronchial use to control hemoptysis or debulk tumors. Advanced stent delivery systems-often preloaded, self-expanding, and customizable in length and diameter-are improving treatment outcomes in airway stenosis and post-surgical strictures. Furthermore, endotherapy devices are now being designed with embedded sensors for real-time feedback on temperature, pressure, and positioning, thereby minimizing human error and enhancing procedural reproducibility.

How Do Clinical Protocols and Regional Healthcare Infrastructure Shape Market Penetration?

The adoption of respiratory endotherapy devices is highly influenced by local clinical protocols, reimbursement frameworks, and the availability of interventional pulmonology infrastructure. In high-income regions such as the U.S., Germany, Japan, and South Korea, respiratory endotherapy is increasingly being adopted as standard-of-care in tertiary centers for both diagnostic and therapeutic purposes. Hospitals in these countries are equipped with advanced imaging modalities, integrated operating suites, and trained interventional pulmonologists who can utilize the full spectrum of devices. Reimbursement for minimally invasive procedures and post-acute respiratory care is also well established in these regions, further encouraging adoption.

In contrast, middle-income regions such as Southeast Asia, Eastern Europe, and Latin America are witnessing growing interest in respiratory endotherapy, but uptake is often constrained by cost considerations and limited technical expertise. Nevertheless, the expansion of public-private partnerships and telemedicine-based training platforms is helping to bridge the skills gap. In India, China, and Brazil, government and non-profit initiatives targeting early detection and management of respiratory diseases are spurring demand for cost-effective, locally adapted endotherapy solutions. Mobile bronchoscopy units and outpatient interventional programs are beginning to appear in urban hospitals, bringing endotherapy within reach of a broader patient demographic.

What Is Sustaining Long-Term Growth in the Respiratory Endotherapy Devices Market?

The growth in the respiratory endotherapy devices market is driven by several factors, including the increasing prevalence of chronic respiratory diseases, rising demand for minimally invasive interventions, and ongoing innovation in procedural tools. A major growth driver is the shift toward ambulatory care models and outpatient interventions. With healthcare systems under pressure to reduce inpatient costs and surgical complications, bronchoscopic endotherapy provides a viable alternative that aligns with the goals of value-based care. The demand for these procedures is further fueled by the rise in early diagnosis of respiratory and thoracic conditions, often detected through low-dose CT scans and AI-assisted radiology.

In addition, the expanding role of interventional pulmonology as a distinct subspecialty is creating a robust clinical base for the adoption of advanced endotherapy tools. Hospitals and training centers are investing in simulation labs, hybrid ORs, and AI-guided procedural planning systems to support a new generation of pulmonary specialists. From a technology standpoint, the ongoing convergence of robotics, imaging, and material science is unlocking possibilities such as autonomous navigation, precision drug delivery, and nanocoated stents with anti-inflammatory properties.

Finally, global health policy initiatives focusing on respiratory health-such as the WHO’s Global Action Plan for the Prevention and Control of NCDs-are creating a favorable policy environment for investment and innovation in this domain. With aging populations, rising urban morbidity, and the continuing threat of respiratory pandemics, the role of endotherapy in managing pulmonary health is set to grow substantially. Future devices are expected to become more affordable, personalized, and digitally connected, securing a long-term trajectory of growth for this high-impact medical segment.

SCOPE OF STUDY:

The report analyzes the Respiratory Endotherapy Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Device (Diagnostic Devices, Therapeutic Devices); Specialist (Hospitals Specialist, Diagnostic Centers Specialist, Ambulatory Surgery Centers Specialist); End-Use (Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use, Interventional Radiology End-Use, Venous End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• Ambu
• Armstrong Medical
• Boston Scientific
• CONMED Corporation
• Cook Medical
• Dragerwerk
• Fisher & Paykel Healthcare
• Flexicare Medical
• Getinge
• Halyard Health (Avanos Medical)
• Hudson RCI
• Intersurgical
• Karl Storz
• Laerdal Medical
• Medtronic
• Olympus
• PENTAX Medical
• Philips (Philips Respironics)
• ResMed
• Teleflex

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Respiratory Endotherapy Devices - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Incidence of Chronic Respiratory Diseases Propels Demand for Endotherapy Interventions
  • Aging Global Population Base Strengthens Business Case for Minimally Invasive Pulmonary Procedures
  • Increased Diagnosis Rates of COPD and Asthma Accelerate Device Utilization in Bronchoscopic Therapies
  • Advances in Flexible Endoscopic Technologies Expand Addressable Market for Precision Treatment
  • Surge in Demand for Non-Surgical Alternatives Spurs Adoption of Respiratory Endotherapy Devices
  • Integration of Imaging-Guided Navigation Systems Enhances Procedure Success and Market Uptake
  • Emergence of Endobronchial Valves and Coils Drives Innovation in Severe Emphysema Treatment
  • Growing Focus on Daycare and Outpatient Bronchoscopy Strengthens Demand for Disposable Instruments
  • Hospital Budget Constraints Propel Preference for Reusable and Sterilizable Device Configurations
  • Expanding Adoption in Lung Cancer Diagnosis and Palliative Care Broadens Use-Case Scenarios
  • Clinical Trials and Regulatory Approvals Accelerate Market Penetration of Novel Endotherapy Solutions
  • Public and Private Investment in Respiratory Research Fuels Device Development Pipelines
  • Increased Demand for Airway Stenting and Dilatation Enhances Market Versatility
  • High Burden of Smoking-Related Lung Damage Throws the Spotlight on Therapeutic Endoscopy
  • Integration with AI-Based Bronchoscopic Mapping Systems Drives Procedural Efficiency
  • Surge in ICU Admissions and Ventilation-Related Complications Boosts Procedural Frequency
  • Training and Simulation Tools Enhance Adoption Rates Among Pulmonologists and Interventionalists
  • Decentralization of Respiratory Care to Ambulatory Settings Expands Market Reach
  • Innovations in Biodegradable Implants Open New Frontiers in Chronic Disease Management
  • Rising Healthcare Spending in Emerging Markets Spurs Procurement of Advanced Endotherapy Systems
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Respiratory Endotherapy Devices Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Respiratory Endotherapy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Respiratory Endotherapy Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Diagnostic Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Diagnostic Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Diagnostic Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Therapeutic Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Therapeutic Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Therapeutic Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Venous End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Venous End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Venous End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Peripheral Vascular Intervention End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Peripheral Vascular Intervention End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Peripheral Vascular Intervention End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Endovascular Interventions End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Endovascular Interventions End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Endovascular Interventions End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Cardiac End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Cardiac End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Cardiac End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Interventional Radiology End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Interventional Radiology End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Interventional Radiology End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Hospitals Specialist by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Hospitals Specialist by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Hospitals Specialist by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Diagnostic Centers Specialist by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Diagnostic Centers Specialist by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 34: World 16-Year Perspective for Diagnostic Centers Specialist by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers Specialist by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Ambulatory Surgery Centers Specialist by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 37: World 16-Year Perspective for Ambulatory Surgery Centers Specialist by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Respiratory Endotherapy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 38: USA Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 40: USA 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 43: USA 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 46: USA 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 49: Canada 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 52: Canada 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 55: Canada 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• JAPAN
  • Respiratory Endotherapy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 58: Japan 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 61: Japan 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 64: Japan 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• CHINA
  • Respiratory Endotherapy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 65: China Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 67: China 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 68: China Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 70: China 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 71: China Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 73: China 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• EUROPE
  • Respiratory Endotherapy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Respiratory Endotherapy Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 76: Europe 16-Year Perspective for Respiratory Endotherapy Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 79: Europe 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 82: Europe 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 85: Europe 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• FRANCE
  • Respiratory Endotherapy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 86: France Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 88: France 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 89: France Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 91: France 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 92: France Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 94: France 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• GERMANY
  • Respiratory Endotherapy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 97: Germany 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 100: Germany 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 103: Germany 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 106: Italy 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 109: Italy 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 112: Italy 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Respiratory Endotherapy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 113: UK Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 115: UK 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 116: UK Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 118: UK 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 119: UK Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 121: UK 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 124: Spain 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 127: Spain 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 130: Spain 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 133: Russia 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 136: Russia 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 139: Russia 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Respiratory Endotherapy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Respiratory Endotherapy Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 16-Year Perspective for Respiratory Endotherapy Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Respiratory Endotherapy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 163: Australia 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 166: Australia 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 167: Australia Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 169: Australia 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• INDIA
  • Respiratory Endotherapy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 170: India Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 172: India 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 173: India Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 175: India 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 176: India Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 178: India 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 181: South Korea 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 184: South Korea 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 187: South Korea 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Respiratory Endotherapy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Respiratory Endotherapy Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 199: Latin America 16-Year Perspective for Respiratory Endotherapy Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 202: Latin America 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 205: Latin America 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 208: Latin America 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 211: Argentina 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 214: Argentina 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 217: Argentina 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 220: Brazil 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 223: Brazil 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 226: Brazil 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 229: Mexico 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 232: Mexico 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 235: Mexico 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Respiratory Endotherapy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Respiratory Endotherapy Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 247: Middle East 16-Year Perspective for Respiratory Endotherapy Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 250: Middle East 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 253: Middle East 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 256: Middle East 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 259: Iran 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 262: Iran 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 263: Iran Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 265: Iran 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 268: Israel 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 271: Israel 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 272: Israel Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 274: Israel 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 286: UAE 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 289: UAE 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 290: UAE Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 292: UAE 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• AFRICA
  • Respiratory Endotherapy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 304: Africa 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 307: Africa 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 308: Africa Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 310: Africa 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030

IV. COMPETITION